Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03970122 · ClinicalTrials.gov registry record · Phase 1
FIH Ph 1 Study of TRPC5 Channel Inhibitor GFB-887 in Healthy Subjects
A Phase 1 study, sponsored by Goldfinch Bio.
- Completed
- Registry status
- Phase 1
- Development phase
- 70
- Enrollment target
NCT03970122 is a Phase 1 study that has completed, run by Goldfinch Bio. The registered enrollment target is 70 participants.
The verdict
NCT03970122, a Phase 1 study, has completed, sponsored by Goldfinch Bio.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 70 participants
- Enrollment target
Study Summary
The study will comprise primarily a single-ascending dose (SAD) escalation component.
Interventions
- DRUG Placebo
- DRUG GFB-887
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2019-05-29 |
| Est. Completion | 2020-04-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03970122
The ClinicalTrials.gov registry entry for NCT03970122 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Goldfinch Bio, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03970122 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03970122 about?
NCT03970122 is a clinical study titled "FIH Ph 1 Study of TRPC5 Channel Inhibitor GFB-887 in Healthy Subjects". The study will comprise primarily a single-ascending dose (SAD) escalation component.
What is the current status of trial NCT03970122?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 70 participants. The study started on 2019-05-29. Estimated completion is 2020-04-04.
What interventions are being tested in trial NCT03970122?
The interventions under investigation include: Placebo (DRUG), GFB-887 (DRUG).
Who is sponsoring clinical trial NCT03970122?
This trial is sponsored by Goldfinch Bio, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.